GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Capital Reinvestment Ratio
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Capital Reinvestment Ratio of 0.32x as of September 2020, meaning it reinvests 0% of its operating cash flow (Rs1.23 Billion) in capital expenditures (Rs389.75 Million). See GlaxoSmithKline Pharmaceuticals Limited (GLAXO) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GlaxoSmithKline Pharmaceuticals Limited Capital Reinvestment Ratio (2005–2025)
This chart tracks GlaxoSmithKline Pharmaceuticals Limited's Capital Reinvestment Ratio across 21 annual periods.
Annual Capital Reinvestment Ratio for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year Capital Reinvestment Ratio for GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. For live market cap and broader valuation context, see how much is GlaxoSmithKline Pharmaceuticals Limited worth.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | Rs12.90 Billion | Rs230.20 Million | ▼ -66.7% |
| 2024 | 0.05x | Rs5.82 Billion | Rs312.21 Million | ▼ -41.0% |
| 2023 | 0.09x | Rs4.84 Billion | Rs440.40 Million | ▲ +112.9% |
| 2022 | 0.04x | Rs8.11 Billion | Rs346.41 Million | ▼ -44.2% |
| 2021 | 0.08x | Rs5.78 Billion | Rs442.27 Million | ▼ -75.9% |
| 2020 | 0.32x | Rs4.90 Billion | Rs1.56 Billion | ▼ -56.4% |
| 2019 | 0.73x | Rs3.99 Billion | Rs2.91 Billion | ▼ -14.5% |
| 2018 | 0.85x | Rs4.73 Billion | Rs4.03 Billion | ▼ -33.9% |
| 2017 | 1.29x | Rs2.36 Billion | Rs3.04 Billion | ▼ -22.7% |
| 2016 | 1.67x | Rs1.39 Billion | Rs2.32 Billion | ▲ +245.5% |
| 2015 | 0.48x | Rs2.70 Billion | Rs1.30 Billion | ▲ +133.4% |
| 2014 | 0.21x | Rs2.81 Billion | Rs582.22 Million | ▲ +66.1% |
| 2013 | 0.12x | Rs3.14 Billion | Rs390.76 Million | ▼ -0.6% |
| 2012 | 0.13x | Rs3.36 Billion | Rs420.95 Million | ▲ +181.0% |
| 2011 | 0.04x | Rs4.79 Billion | Rs213.94 Million | ▼ -24.8% |
| 2010 | 0.06x | Rs5.12 Billion | Rs303.67 Million | ▼ -17.9% |
| 2009 | 0.07x | Rs3.30 Billion | Rs238.79 Million | ▲ +50.5% |
| 2008 | 0.05x | Rs3.19 Billion | Rs153.26 Million | ▼ -33.3% |
| 2007 | 0.07x | Rs2.59 Billion | Rs186.23 Million | ▲ +7.6% |
| 2006 | 0.07x | Rs3.49 Billion | Rs233.91 Million | ▲ +63.6% |
| 2005 | 0.04x | Rs2.29 Billion | Rs93.72 Million | — |